Home/ Supplements/ Vitamin C/ Max Brain

Max Brain

product on market Capsule XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 44% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains B vitamins and antioxidants, which are supported by strong evidence for maintaining cellular energy and neurological function. These ingredients contribute to cognitive health by protecting cells from oxidative stress. However, the overall evidence coverage for this specific ingredient profile is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Max Brain
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
44%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin C
5 mg (8% DV)
10 IU (33% DV)
Within RDA (0.4× RDA) 179 studies (A:3, B:90)
5 mg (333% DV)
4.2× RDA — above typical dose 76 studies (A:0, B:33)
4 mg (20% DV)
Within RDA (0.3× RDA) 196 studies (A:5, B:63)
5 mg (250% DV)
3.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
100 mcg (25% DV)
Within RDA (0.2× RDA) 226 studies (A:10, B:105)
5000 mcg (83333% DV)
2083.3× RDA — above typical dose 139 studies (A:1, B:44)
Calcium
15 mg (2% DV)
12 mg (3% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
5 mg (33% DV)
Within RDA (0.5× RDA) 263 studies (A:6, B:134)
50 mcg (71% DV)
Within RDA (0.9× RDA) 173 studies (A:0, B:67)
0.05 mg (25% DV)
Market median: 10.0mg (102 products) 9 studies — no high-quality reviews
50 mcg (42% DV)
1.4× RDA — within safe limits 199 studies (A:1, B:55)
Potassium
5 mg (1% DV)
DMAE
30 mg
Rosemary extract
50 mg
Market median: 125.0mg (294 products) 38 studies (A:1, B:7)
Angelica sinensis
25 mg
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)
Market median: 340.0mg (243 products) 3 studies — no high-quality reviews
Market median: 100.0mg (108 products)
Market median: 120.0mg (440 products) 191 studies (A:1, B:71)
10 mg
Market median: 420.0mg (227 products)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
500 mcg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
9 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
S-Acetyl Glutathione
5 mg
Market median: 30.0mg (45 products)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
5 mg
Market median: 500.0mg (143 products)
25 mcg
Market median: 0.15mg (41 products)
2 mg
Market median: 100.0mg (116 products) 18 studies (A:0, B:3)
L-Ornithine
1 mg
1 mg
Market median: 500.0mg (159 products)
Market median: 500.0mg (193 products) 7 studies — no high-quality reviews
Vinpocetine
500 mcg

Other Ingredients

Microcrystalline Cellulose HPMC Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions: Take one capsule daily, or as directed by your healthcare practitioner.

Warnings & Precautions

Consult your healthcare practitioner prior to use.

Individuals taking medication should discuss potential interactions with their healthcare practitioner.

Contains: Soy.

Formulation Notes

Does not contain: Wheat, gluten, yeast, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, artificial colors, artificial sweeteners, or preservatives.

Contains: Soy.

Additional Information

Quatrefolic

ZLB-BAZBRAIN-03 REV. 102814

VEGETARIAN CAPS

THIRD-PARTY VERIFIED GMP COMPLIANT

Scan To Learn More!

This package is completely recyclable

Professional use only

Storage: Keep tightly closed in a cool, dry place.

ePV

Exclusive Professional Formulas

Metadata

Product Details

UPC / SKU8 71149 00380 7
DSLD Entry Date2015-09-25
Product TypeOther Combinations
FormCapsule
BrandXYMOGEN
DSLD ID50373
Data Updated2026-04-11
Research

Research Evidence

371
Research Sources
54
Avg Quality
148
Meta Analysis
82
Systematic Review
71
Rct
62
Clinical Trial
2
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Other
1
Openfda Safety
A Vitamin C supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin C supplementation for the primary prevention of cardiovascular disease
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin C for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Vitamin C for preventing and treating pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Vitamin E supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Nutritional interventions for preventing and treating pressure ulcers
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Does Vitamin C Supplementation Provide a Protective Effect in Periodontal Health? A Systematic Review and Meta-Analysis
Meta Analysis International journal of molecular sciences 2024 PubMed DOI
A Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study
Meta Analysis BMC medicine 2021 PubMed DOI
View all evidence for Vitamin C →
Compare

Similar Products

View all Vitamin C products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.